Optimizing treatment for nasal NK T-cell lymphoma.
a Peter MacCallum Cancer Institute , Grattan St , Melbourne , Australia ;
Andrew
A
Wirth
b The University of Texas, M.D. Anderson Cancer Center, Radiation Oncology , Houston , TX , United States.
Bouthaina
B
Dabaja
D054747:Histiocytic Sarcoma; D006801:Humans; D007694:Killer Cells, Natural; D054391:Lymphoma, Extranodal NK-T-Cell; D016411:Lymphoma, T-Cell, Peripheral